Biopharmaceuticals
A biopharmaceutical also called as a biological medical by-product, biologic is other pharmaceutical drug by-product produce in, draw out from, or semi synthesized from biological origin. Distinct from completely synthesized pharmaceuticals, they also contain vaccines, complete blood, blood products, allergenic, somatic cells, gene therapies, tissues, recombinant therapeutic protein, and living drugs used in cell remedyHaematopoietic Growth Factors.
- Gene Theraphy
Related Conference of Biopharmaceuticals
October 13-14, 2025
17th International Conference on Tissue Science and Regenerative Medicine
Rome, Italy
Biopharmaceuticals Conference Speakers
Recommended Sessions
- Biomedical Engineering
- Biomedical Polymer and Metal Materials
- Biopharmaceuticals
- Bioprocessing
- Biosensors for Environmental Monitoring
- Biosensors, Bio-sensing Technologies
- Cancer Biotechnology
- Lab-on-a-chip and Multiplexed Sensors
- Microfluidics-Technology & Healthcare
- Nanoparticles in Biopharmaceuticals
- Optical Biosensors
- Pharmaceutical formulation, in pharmaceutics
- Pharmaceutical Nanotechnology
- Bioenergy and Bio-renewables
- Bioinstrumentation
- Biomaterials
- Biosensors in Drug Discovery
- Cell therapy bioprocessing and commercialization
- Clinical Trials and Clinical Research
- Drug Regulations Quality Assurance
- Environmental Biosensors
- Enzyme-Based Biosensors
- Industrial Biotechnology
- Tissue Engineering& DNA Technology Drug Therapies
Related Journals
Are you interested in
- 3-D Structure Determination - Structural Biology 2025 (Germany)
- 3D Structure Determination - Structural Biology-2025 (France)
- Advanced Techniques in Structural Biology - Structural Biology-2025 (France)
- Advancements in structural Biology - Structural Biology 2025 (Germany)
- AI & Computational Structural Biology - Structural Biology-2025 (France)
- Biochemistry and Biophysics - Structural Biology-2025 (France)
- Biochemistry and Biophysics - Structural Biology 2025 (Germany)
- Computational Approach in Structural Biology - Structural Biology-2025 (France)
- Computational Approach in Structural Biology - Structural Biology 2025 (Germany)
- Drug Designing and Biomarkers - Structural Biology-2025 (France)
- Drug Designing and Biomarkers - Structural Biology 2025 (Germany)
- Frontiers in Structural Biology - Structural Biology 2025 (Germany)
- Gene Regulation and Cell Signaling - Structural Biology 2025 (Germany)
- Hybrid Approaches for Structure Prediction - Structural Biology-2025 (France)
- Hybrid Approaches in Structure Prediction - Structural Biology 2025 (Germany)
- Membrane Proteins and Receptors - Structural Biology-2025 (France)
- Molecular Biology - Structural Biology 2025 (Germany)
- Molecular Biology Techniques - Structural Biology 2025 (Germany)
- Molecular Modelling and Dynamics - Structural Biology-2025 (France)
- Molecular Modelling and Dynamics - Structural Biology 2025 (Germany)
- Proteomics and Genomics - Structural Biology 2025 (Germany)
- Proteomics and Genomics - Structural Biology-2025 (France)
- Sequencing Analysis - Structural Biology 2025 (Germany)
- Structural Bioinformatics - Structural Biology 2025 (Germany)
- Structural Bioinformatics and Computational Biology - Structural Biology-2025 (France)
- Structural Biology - Structural Biology 2025 (Germany)
- Structural Biology Databases - Structural Biology 2025 (Germany)
- Structural Biology in Cancer Research - Structural Biology-2025 (France)
- Structural Biology in Cancer Research - Structural Biology 2025 (Germany)
- Structural Enzymology - Structural Biology 2025 (Germany)
- Structural Virology - Structural Biology-2025 (France)
- Structural Virology and Infectious Diseases - Structural Biology-2025 (France)
- Structure-Based Drug Discovery - Structural Biology-2025 (France)
- Structure-Based Solutions to Global Health Challenges - Structural Biology-2025 (France)
- Structure-Function Relationships - Structural Biology-2025 (France)
- The Structural Basis of Disease - Structural Biology-2025 (France)